Suchergebnisse - "Tarabar, Sanela"

PubPharm (23)

1

Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis : A Randomized Clinical Trial

enthalten in: JAMA dermatology | 2024

von Eichenfield, L. | Tarabar, S. | Forman, S. | +7

2

Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis : a phase IIb randomized double-blind vehicle-controlled parallel-group study

enthalten in: The British journal of dermatology | 2023

von Landis, M. | Smith, S. | Berstein, G. | +10

CommentIn: Br J Dermatol. 2023 May 08;:. - PMID 37151092

3

Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis : a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study

enthalten in: The British journal of dermatology | 2022

von Landis, M. | Arya, M. | Smith, S. | +11

CommentIn: Br J Dermatol. 2022 Dec;187(6):838. - PMID 36199210

4

Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled study

enthalten in: Journal of the American Academy of Dermatology | 2022

von Tehlirian, C. | Singh, R. | Pradhan, V. | +5

5

Efficacy and safety of topical brepocitinib for the treatment of mild‐to‐moderate atopic dermatitis : a phase IIb, randomized, double‐blind, vehicle‐controlled, dose‐ranging and parallel‐group study*

enthalten in: British Journal of Dermatology | 2022

von Landis, M. | Arya, M. | Smith, S. | +11

6

Safety, Tolerability, and Pharmacokinetics of PF-06823859, an Anti-Interferon β Monoclonal Antibody : A Randomized, Phase I, Single- and Multiple-Ascending-Dose Study

enthalten in: Clinical pharmacology in drug development | 2021

von Neelakantan, S. | Oemar, B. | Johnson, K. | +8

7

Safety, Tolerability, and Pharmacokinetics of PF‐06823859, an Anti–Interferon β Monoclonal Antibody : A Randomized, Phase I, Single‐ and Multiple‐Ascending‐Dose Study

enthalten in: Clinical Pharmacology in Drug Development | 2021

von Neelakantan, S. | Oemar, B. | Johnson, K. | +8

8

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver-Targeting Acetyl-CoA Carboxylase Inhibitor (PF-05221304) : A Three-Part Randomized Phase 1 Study

enthalten in: Clinical pharmacology in drug development | 2020

von Bergman, A. | Carvajal-Gonzalez, S. | Tarabar, S. | +3

9

Phase I Pharmacokinetic Study of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in Healthy Adult and Adolescent Populations

enthalten in: Drugs in R&D | 2020

von Tarabar, S. | Kelsh, D. | Vince, B. | +6

10

Phase I Pharmacokinetic Study of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in Healthy Adult and Adolescent Populations

enthalten in: Drugs in R & D | 2020

von Tarabar, S. | Kelsh, D. | Vince, B. | +6